Influencing the sirtuins by small molecule pharmaceuticals in order to simulate a metabolic state resembling caloric restriction, and thereby preventing ageing and age-related diseases such as obesity, diabetes and cardiovascular disease, is currently a hotly debated field (53), but outside the scope of this article.